Back to Industry News
Medtech
Pfizer Nears $7.3B Metsera Takeover for Obesity Market
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Bloomberg
Photo by Diana Polekhina on Unsplash
Stay updated on stories like this
Key takeaways
- is reportedly nearing a $7
- 3 billion acquisition of obesity startup Metsera Inc
- , according to a Financial Times report
Pfizer Inc. is reportedly nearing a $7.3 billion acquisition of obesity startup Metsera Inc., according to a Financial Times report. This potential acquisition would significantly bolster Pfizer's pipeline, especially following the recent setback of its own closely monitored weight-loss pill.
Citing individuals with knowledge of the situation, the Financial Times indicated that an agreement could be announced as early as Monday.
Related Topics
PfizerMetseraAcquisitionObesity MarketMedtechBiopharmaceuticals
Never miss stories like this